首页> 美国政府科技报告 >Diagnosis, Prognosis, and Treatment of Impaired Glucose Tolerance and Impaired Fasting Glucose. Evidence Report/Technology Assessment Number 128.
【24h】

Diagnosis, Prognosis, and Treatment of Impaired Glucose Tolerance and Impaired Fasting Glucose. Evidence Report/Technology Assessment Number 128.

机译:葡萄糖耐量受损和空腹葡萄糖受损的诊断,预后和治疗。证据报告/技术评估编号128。

获取原文

摘要

This systematic review evaluated the evidence to address the following research questions: (1) What is the test reproducibility of the diagnosis of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT). (2) What is the relationship between IFG and IGT. For those individuals identified with IFG or IGT, what are the short- and long-term risks for developing negative health outcomes. Does this risk vary by subpopulation, such as sex, race, obesity, age, or other such risk factors as blood pressure or elevated lipid levels. (3) What is the effectiveness of pharmaceutical and behavioral interventions for reducing the risks associated with IFG/IGT. Are some treatments more effective than others, and does the effectiveness of interventions vary by subpopulation (e.g., age, sex, and obesity). (4) What is known about the development of IFG/IGT in the pediatric population.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号